Irisin levels exhibit a robust correlation with health status, revealing markedly diminished levels in individuals afflicted with obesity, osteoporosis, reduced bone mass, muscular dystrophy, and cardiovascular disease, while cancer patients manifest elevated irisin levels (80). The gene discussed is FNDC5; the disease is obesity disorder.